Skip to main content
Thurl E Harris, PhD

Thurl E Harris, PhD

Professor and Director of Graduate Studies, Pharmacology

Primary Location
PO Box 800735
1340 Jefferson Park Ave., Pinn Hall, Room 5221B
Charlottesville, VA 22908
Primary Phone Number
Fax Number
434.982.3878

Bio & Overview

As Paleolithic hunter gatherers, the human diet was relatively low in fats and simple carbohydrates. Technological advances, beginning with the agricultural revolution 12,000 years ago and culminating with the mechanization of food production in the last century, have provided a significant portion of the world’s population with access to inexpensive, energy-dense food. In the modern age the ready availability of carbohydrates and fats, combined with a large reduction in physical labor, has led to a predictable rise in obesity. The Center for Disease Control estimates currently ~34% of the U.S. population is characterized as overweight (B.M.I. of 25-30), and another 40% are obese (B.M.I.>30), giving an astonishing 3 out 4 Americans defined as overweight or obese. As an underlying risk factor for type II diabetes and cardiovascular disease, understanding how obesity promotes the development of these diseases is of extreme importance for worldwide health. As part of the Department of Pharmacology, the Harris Lab uses animal models to study how obesity promotes insulin resistance. At a basic level, we are interested in how adipose tissue responds to anabolic (insulin) and catabolic (catecholamines) hormones to regulate adiposity and whole body metabolic homeostasis. We use genetic models and pharmacological tools to evaluate adipose function in mice. We are also interested in the molecular mechanisms regulating insulin and counterregulatory hormone signaling in adipocytes, with special interest in the mammalian Target of Rapamycin (mTOR) and downstream effectors such as the Mast kinase family. This work also includes biochemical studies on enzymes that regulate lipid synthesis and breakdown, with a particular interest in the lipin family (phosphatidic acid phosphatases), and the diacylglycerol kinase family of enzymes

Academic Information

Department
Pharmacology
Academic Title
Associate Professor

Primary Education

  • PhD, Cell & Molecular Biology, Baylor College of Medicine, 2001

Other Appointments

  • Pharmacology
  • Endocrinology
  • Assistant Professor, MOMD

Other Affiliations

  • Cancer Center
  • Member, Cancer Center
  • Pharmacology
  • Physiology
  • Member, Cardiovascular Research Center
  • Cardiovascular Research Center
  • MSTP
  • Assistant Professor, BIMS
  • BIMS

Research Interests

Molecular mechanisms controlling insulin signaling and fat synthesis.

Research Disciplines

  • Biochemistry
  • Biology
  • Biotechnology
  • Cancer Biology
  • Cardiovascular Biology
  • Epigenetics
  • Kinesiology
  • Metabolism
  • Molecular Biology
  • Molecular Pharmacology
  • Molecular and Cellular Physiology
  • Physiology
  • Translational Science

Research Opportunities

  • Biochemistry
  • Biotechnology
  • Cancer Biology
  • Cardiovascular Disease
  • Cellular and Molecular Metabolism
  • Epigenetics
  • Molecular Biology
  • Molecular Pharmacology
  • Physiological Basis of Human Disease

PhD Programs

  • Pharmacology

Selected Publications

2026

2025

2024

2023

2022

2021

Adaptive thermogenesis in brown adipose tissue involves activation of pannexin-1 channels
Molecular Metabolism. 2021; 44: 101130. DOI:10.1016/J.MOLMET.2020.101130.

Adipose‐specific ATGL ablation reduces burn injury‐induced metabolic derangements in mice
Clinical and Translational Medicine. 2021; 11(6):. DOI:10.1002/CTM2.417.

Atglistatin Pretreatment Preserves Remote Myocardium Function Following Myocardial Infarction
Journal of Cardiovascular Pharmacology and Therapeutics. 2021; 26(3): 289 - 297. DOI:10.1177/1074248420971113.

Cell cycle regulation of ER membrane biogenesis protects against chromosome missegregation
Developmental Cell. 2021; 56(24): 3364 - 3379.e10. DOI:10.1016/J.DEVCEL.2021.11.009.

Loss of Diacylglycerol Kinase α Enhances Macrophage Responsiveness
Frontiers in Immunology. 2021; 12:. DOI:10.3389/FIMMU.2021.722469.

Reduced adiponectin levels in patients with COVID‐19 acute respiratory failure: A case‐control study
Physiological Reports. 2021; 9(7):. DOI:10.14814/PHY2.14843.

2020

2019

2018

2017